Australia's largest stock trading and investment forum Australia's #1 stock forum

AHI

Click for more information

0.00%

9.2¢ advanced health intelligence ltd

I have to agree. The frequency with which these deals are coming...

First 13 Last

Share
Profile

Follow
DoriansMirror

4,077 Posts.

477

08/10/20

11:29

Post #: 47937774
Share

Originally posted by Day424: ↑

Yeah dude, I swear I've never seen a company release deal after deal with such momentum and flow before. Most other companies release 1 deal every few months and then spend ages on trying to make it work (or not work) and then goes dead in the water. MYQ has deals with minimum users, minimum revenue, and it's got trains full of these upcoming deals that are still happening so even if a few go dead in the water, MYQ's revenue will still take off like no tomorrow.

I appreciate that they need to go live, but the momentum says this is just a numbers game, the revenues are all going to snowball from each of these deals and any single one is a company maker, let alone the 10+ they have already secured/in the pipeline.

I swear Vlado doesn't sleep, in fact he actually doesn't when a lot of these deals are in the US where the timezone to work there is our graveyard shift.

Expand

I have to agree. The frequency with which these deals are coming out is amazing.

I've been one to want to temper claims that Vlado is doing an amazing job. If these deals actually launch, I will be prepared to say Vlado is doing an amazing job.

Not until then, however.

MYQ Price at posting: $1.34 Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 3 more messages in this thread...

First 13 Last

Add AHI (ASX) to my watchlist